ASKA Biotech announces management board changes
ASKA Biotech starts the year with more exciting news. After the successful implementation of ISO 9001:2015 ASKA Biotech had some arrangements in the management board.
New Management Board at ASKA Biotech(firmenpresse) - Hennigsdorf, 03.03.2020 - ASKA Biotech announced new members of it’s management. The current owner and CEO Siegmund Karasch will be supported from now on by Anke Holzinger and Alexandra Rindermann.
Since October 2019 all three members built up together the ASKA business to provide customers independent high-quality services for development and production of monoclonal antibodies and recombinant proteins.
Siegmund Karasch knows both since over 8 years and worked with them already in his former business. He said, “I´m happy to make up the management board with these two ladies. I know them well from my last company and I´m confident, that we will complement each other to push ASKA Biotech forward.”
Anke Holzinger will be in charge for Business Development and Marketing department at ASKA Biotech and accelerates the digital transformation of the processes. “I´m looking forward to boost the services and business with the team. Next to further protein analysis methods we will implement a new platform to provide our customers a new ordering journey.”
Alexandra Rindermann represents the Quality Management and Quality Control department. “My focus will be reinforcement of our quality management system according DIN EN ISO 9001:2015 and the system set up according ISO 13485. Next to our current services, we will extend the service portfolio for protein analysis and characterization.”
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
About ASKA Biotech:
ASKA Biotech GmbH is an independent ISO 9001:2015 certified contract manufacturing organization for the development and production of monoclonal antibodies and recombinant proteins for research, in-vitro diagnostic and preclinical trials. ASKA Biotech provides customized and flexible solutions for each specific requirement. In addition, ASKA Biotech offers various analytical methods to characterize the produced proteins. Immunoassay development, production and sample analysis complete the service portfolio. Based in Hennigsdorf, next to Berlin, ASKA Biotech started with the setup of the production facility in 2019.
Datum: 03.03.2020 - 17:37 Uhr
Sprache: Deutsch
News-ID 608403
Anzahl Zeichen: 1626
contact information:
Contact person: Anke Holzinger
Town:
Hennigsdorf
Phone: +4915142868434
Kategorie:
Pharmaceuticals & Biotech
Typ of Press Release: Personel
type of sending: send
Date of sending: 03.03.2020
Diese Pressemitteilung wurde bisher 423 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"ASKA Biotech announces management board changes"
steht unter der journalistisch-redaktionellen Verantwortung von
ASKA Biotech GmbH (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
